Corporate Governance | Regeneron Pharmaceuticals Inc.

Date	Name	Title	Filing	Type	Shares Traded	Price	Total Held
Feb 18, 2014	Aberman Michael S VP Strategy and Investor Relat	VP Strategy and Investor Relat	Form 4	Open market or private sale of non-derivative or derivative security	948	$333.50	15,900
Mar 24, 2015	Aberman Michael S SVP Strategy Investor Relation	SVP Strategy Investor Relation	Form 4	Open market or private sale of non-derivative or derivative security	740	$476.53	16,101
Apr 30, 2012	Aberman Michael S VP Strategy and Investor Relat	VP Strategy and Investor Relat	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	4,170	$138.31	16,162
May 24, 2012	Aberman Michael S VP Strategy and Investor Relat	VP Strategy and Investor Relat	Form 4	Exercise or conversion of derivative security exempted pursuant to Rule 16b-3	500	--	16,164
Dec 17, 2015	Aberman Michael S SVP Strategy Investor Relation	SVP Strategy Investor Relation	Form 4	Exercise or conversion of derivative security exempted pursuant to Rule 16b-3	4,000	$24.00	16,498
May 14, 2013	Aberman Michael S VP Strategy and Investor Relat	VP Strategy and Investor Relat	Form 4	Open market or private sale of non-derivative or derivative security	701	$278.72	16,528
Sep 02, 2011	Aberman Michael S VP Strategy and Investor Relat	VP Strategy and Investor Relat	Form 4	Exercise or conversion of derivative security exempted pursuant to Rule 16b-3	4,166	--	16,664
Dec 10, 2012	Aberman Michael S VP Strategy and Investor Relat	VP Strategy and Investor Relat	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	1,257	$182.68	16,743
Mar 24, 2015	Aberman Michael S SVP Strategy Investor Relation	SVP Strategy Investor Relation	Form 4	Open market or private sale of non-derivative or derivative security	200	$475.83	16,841
Feb 18, 2014	Aberman Michael S VP Strategy and Investor Relat	VP Strategy and Investor Relat	Form 4	Open market or private sale of non-derivative or derivative security	1,100	$332.41	16,848

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.

Investors & Media